Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6418
    -0.0008 (-0.12%)
     
  • OIL

    82.94
    +0.21 (+0.25%)
     
  • GOLD

    2,409.80
    +11.80 (+0.49%)
     
  • Bitcoin AUD

    99,840.39
    +752.32 (+0.76%)
     
  • CMC Crypto 200

    1,371.72
    +59.10 (+4.50%)
     
  • AUD/EUR

    0.6025
    -0.0006 (-0.09%)
     
  • AUD/NZD

    1.0898
    +0.0023 (+0.21%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,094.30
    -300.01 (-1.72%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,880.22
    +104.84 (+0.28%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Cellebrite Announces Participation in Upcoming Investor Conferences

Cellebrite DI Ltd
Cellebrite DI Ltd

PETAH TIKVA, Israel and TYSONS CORNER, Va., May 03, 2023 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in Digital Intelligence solutions for the public and private sectors, today announced the Company plans to participate in the following investor conferences in May and June:

Date:

May 16, 2023

Conference:

Needham & Co. Technology & Media Conference

Presentation Time:

10:15 a.m. ET

Format

Fireside Chat

Event URL:

https://investors.cellebrite.com/events/event-details/needham-co-18th-annual-technology-and-media-conference

Cellebrite executives:

Dana Gerner, chief financial officer
Andrew Kramer, vice president, investor relations


Date:

May 21, 2023

Conference:

Oppenheimer 24th Annual Israeli Conference

Presentation Time:

5:35 p.m. ET

Format

Fireside Chat

Event URL:

https://investors.cellebrite.com/events/event-details/oppenheimer-24th-annual-israeli-conference

Cellebrite executives:

Dana Gerner, chief financial officer


Date:

May 23, 2023

Conference:

J.P. Morgan 51st Annual Global Technology, Media and Communications Conference

Presentation Time:

5:15 p.m. ET

Format

Fireside Chat

Event URL:

https://investors.cellebrite.com/events/event-details/jp-morgan-51st-annual-global-technology-media-and-communications-conference

Cellebrite executives:

Dana Gerner, chief financial officer
Andrew Kramer, vice president, investor relations


Date:

June 1, 2023

Conference:

TD Cowen 51st Annual Technology, Media & Telecom Conference

Presentation Time:

9:05 a.m. ET

Format:

Fireside Chat

Event URL:

https://investors.cellebrite.com/events/event-details/cowen-51st-annual-technology-media-telecom-conference

Cellebrite executives:

Dana Gerner, chief financial officer
Andrew Kramer, vice president, investor relations


Date:

June 8, 2023

Conference:

William Blair 43rd Annual Growth Stock Conference

Presentation Time:

9:40 a.m. ET

Format:

Presentation

Event URL:

https://investors.cellebrite.com/events/event-details/william-blair-43rd-annual-growth-stock-conference

Cellebrite executives: 

Yossi Carmil, chief executive officer
Dana Gerner, chief financial officer
Andrew Kramer, vice president, investor relations

About Cellebrite
Cellebrite’s (NASDAQ: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com.

ADVERTISEMENT

Media
Victor Cooper
Sr. Director of Corporate Communications + Content Operations
Victor.cooper@cellebrite.com
+1 404.804.5910

Investor Relations
Andrew Kramer
Vice President, Investor Relations
investors@cellebrite.com
+1 973.206.7760